Dror Bashan owns 3.14% of Protalix BioTherapeutics
2,532,934 shares as of the September 3, 2026 filing, worth $6.3M at the latest close.
PLX · $200M market capGet an email when Dror Bashan’s stake moves.
Free.
The stake
3.14%
worth $6.3M at the latest close
Stake rank
#2,004
by dollar value of the stake
Last sale
None
no sales since 2022
Last buy
312 days ago
Dec 19, 2025 · $101,360
Dror Bashan owns 3.14% of Protalix BioTherapeutics, Inc.: 2,532,934 of 80,571,642 shares, worth about $6.3M at the 2026-10-26 close. The stake has moved from 0.00% in 2019 to 3.14% on 2026-09-03, across 0 sales and 3 purchases that moved it since 2016. The last trade that moved it was a discretionary purchase of $101,360 on 2025-12-19.
How the stake is held
as of the Dec 19, 2025 filing
SHARES
OF THE STAKE
COMMON STOCK · stated Dec 19, 2025 · Form 4 ↗
HELD DIRECTLY
188,516
7.4%
HELD INDIRECTLY · By Trust
2,344,418
92.6%
THE STAKE
2,532,934
3.14%